2004
DOI: 10.1016/j.bmc.2004.06.002
|View full text |Cite
|
Sign up to set email alerts
|

A QSAR study on inhibitory activities of 1-phenylbenzimidazoles against the platelet-derived growth factor receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
10
0
3

Year Published

2009
2009
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 20 publications
0
10
0
3
Order By: Relevance
“…It is worth mentioning the case of 1-(4-nitrophenyl)-1H-1,3benzimidazole, (I), which has been reported as an inhibitor of platelet-derived growth factor receptor (PDGFR), which is highly expressed in tumour cells (Zhong et al, 2004;Katritzky et al, 2005). Experimental evidence indicates that the inhibi-tory activity involves discrete noncovalent dipolar proteinligand interactions, which significantly contribute to the binding affinity and to intermolecular recognition.…”
Section: Introductionmentioning
confidence: 99%
“…It is worth mentioning the case of 1-(4-nitrophenyl)-1H-1,3benzimidazole, (I), which has been reported as an inhibitor of platelet-derived growth factor receptor (PDGFR), which is highly expressed in tumour cells (Zhong et al, 2004;Katritzky et al, 2005). Experimental evidence indicates that the inhibi-tory activity involves discrete noncovalent dipolar proteinligand interactions, which significantly contribute to the binding affinity and to intermolecular recognition.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] Although their synthesis has been accomplished successfully using aryllead triacetate, [5][6][7] triarylbismuth, 8 arylstannane, 9 arylsiloxanes 10 and arylboronic acid [11][12][13] reagents etc., these methods often employ expensive reagents or substrates requiring multistep syntheses, and some are highly toxic, which limits their utilization in synthetic chemistry.…”
Section: Introductionmentioning
confidence: 99%
“…Benzimidazoles with N-and C-bonded phenyl-ring substituents have been reported to have a wide range of pharmaceutical activities, such as acting as inhibitors of several growth factors (Katritzky et al, 2005;Smallheer et al, 2004;Zhong et al, 2004) and inhibitors of human cycloxygenases (Secci et al, 2012). Experimental evidence indicates that inhibitory activity involves discrete noncovalent dipolar protein-ligand interactions, which contribute significantly to binding affinity in molecular recognition.…”
Section: Introductionmentioning
confidence: 99%